David M. Berman, HEAD OF R&D at Immunocore Holdings plc (IMCR), sold 54,918 shares at $67.61 ($3.8M) on 2024-02-28, disclosed to the SEC on 2024-03-01.
Scheduled sale ($3.8M) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.61 | 16,900 | $1.1M | 30.2% |
| 2 | $68.84 | 7,472 | $514K | 13.6% |
| 3 | $68.84 | 7,472 | $514K | 13.6% |
| 4 | $69.73 | 10,937 | $763K | 20.2% |
| 5 | $69.73 | 10,937 | $763K | 20.2% |
| 6 | $70.45 | 1,200 |
| $85K |
| 2.2% |
| Total | $68.85 avg | 54,918 | $3.8M | 100% |
| Filing → |
| IMCR | SELL | 2025-12-01 | $6.0M | — | Filing → |
| IMCR | SELL | 2025-11-26 | $1.4M | — | Filing → |
| IMCR | SELL | 2025-10-02 | $4.4M | — | Filing → |